Sutro Biopharma, Inc. Quarterly report pursuant to Section 13 or 15(d)

Stockholders' Equity (Tables)

9 Months Ended

Sep. 30, 2021

The Company has reserved common stock, on an if-converted basis, for issuance as follows:

	September 30,		December 31,
	2021		2020
Common stock options issued and outstanding		6,533,772		5,439,295
Restricted common stock units issued and outstanding		2,262,776		666,375
Remaining shares reserved for issuance under 2004 and 2018 Equity Incentive Plan		1,681,651		1,710,824
Shares reserved for issuance under 2018 Employee Stock Purchase Plan		673,251		361,539
Warrants to purchase common stock		153,070		153,070
Total		11,304,520		8,331,103